Insider Shareholders with Direct Ownership of Capricor Therapeutics, Inc. (CAPR)
This section provides a comprehensive overview of the insiders with direct ownership of Capricor Therapeutics, Inc. (CAPR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CAPRICOR THERAPEUTICS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 2,798,507 | 0 | 7,090,351 $156 Million | 1 |
Sep 20, 2024
Added 28.3%
|
|
|
Linda Marban
CHIEF EXECUTIVE OFFICER |
20,749 | 0 | 198,604 $4.37 Million | 1 |
May 12, 2023
Added 9.46%
|
| 189,318 | 76,440 | 133,269 $2.93 Million | 6 |
Aug 14, 2023
Reduced 3.17%
|
|
| 104,791 | 45,990 | 81,692 $1.8 Million | 9 |
Aug 07, 2024
Added 29.39%
|
|
| 29,305 | 11,761 | 62,147 $1.37 Million | 4 |
Feb 21, 2023
Reduced 0.72%
|
|
| 56,856 | 0 | 56,856 $1.25 Million | 4 |
Apr 23, 2024
Added 34.54%
|
|
|
Karen Krasney
EVP, GENERAL COUNSEL |
18,932 | 0 | 20,047 $440,833 | 1 |
Nov 03, 2022
Added 48.57%
|
| 16,856 | 6,300 | 10,556 $232,126 | 3 |
Feb 14, 2023
Added 11.72%
|
|
| 5,000 | 0 | 5,000 $109,949 | 1 |
Oct 06, 2023
Added 50.0%
|
|
|
Anthony Bergmann
CHIEF FINANCIAL OFFICER |
2,178 | 0 | 2,381 $52,358 | 1 |
Oct 23, 2023
Added 47.77%
|
| 87,291 | 87,791 | 0 $0 | 6 |
Apr 17, 2023
Reduced 100.0%
|